93
Views
88
CrossRef citations to date
0
Altmetric
Original Article

Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection

, , , , , & show all
Pages 131-145 | Received 22 Sep 2003, Accepted 23 Oct 2003, Published online: 07 Jul 2009

  • Kaisho, T. and Akira, S. (2002) "Toll-like receptors as adjuvant receptors", Biochim. Biophys. Acta 1589, 1–13.
  • Akira, SA., Takeda, K. and Kaisho, T. (2001) "Toll-like receptors: critical proteins linking innate and acquired immunity", Nat. Immunol. 2, 675–680.
  • Huber, S.A., Polgar, J., Schultheiss, P. and Schwimmbeck, P. (1994) "Augmentation of pathogenesis of Coxsackievirus infections in mice by exogenous administration of interleukin-1 and interleukin-2", J. Virol. 68, 195–206.
  • Neumann, D.A., Lane, JR., Allen, G.S., Herskowitz, A. and Rose, N.R. (1993) "Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis?", ClM. Immunol. Immuno-pathol. 68, 181–190.
  • Lane, JR., Neumann, D.A., LaFond-Walker, A., Herskowitz, A. and Rose, N.R. (1991) "LPS promotes CB3-induced myocarditis in resistant B10.A mice", Cell. Immunol. 136, 219–233.
  • Lane, JR., Neumann, D.A., LaFond-Walker, A., Herskowitz, A. and Rose, N.R. (1992) "Interleukin 1 or tumor necrosis factor can promote Coxsackievirus B3-induced myocarditis in resistant BlOA mice", J. Exp. Med. 175, 1123–1129.
  • Lenzo, IC., Fairweather, D., Shellam, G.R. and Lawson (James), C.M. (2001) "Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor", Cell. Immunol. 213, 52–61.
  • Fairweather, D., Kaya, Z., Shellam, G.R., Lawson (James), C.M. and Rose, N.R. (2001) "From infection to autoimmunity", J. Autoimmun. 16, 175–186.
  • Feldman, M. (2002) "Development of anti-TNF therapy for rheumatoid arthritis", Nat. Rev. Immunol. 2, 364–371.
  • Firestein, G.S. (2003) "Evolving concepts of rheumatoid arthritis", Nature 423, 356–361.
  • Medzhitov, R. (2001) "Toll-like receptors and innate immunity", Nat. Rev. Immunol. 1, 135–145.
  • Fairweather, D., Yusung, S., Frisancho (Kiss), S., Barrett, M., Gatewood, S., Steele, R. and Rose, N.R. (2003) "IL-12R131 and TLR4 increase IL-113 and IL-18-associated myocarditis and Coxsackievirus replication", J. Immunol. 170, 4731–4737.
  • Tkaczyk, C. and Gilfillan, A.M. (2001) "FceRI-dependent signaling pathways in human mast cells", Glitz. Immunol. 99, 198–210.
  • Prussin, C. and Metcalfe, D.D. (2003) "IgE, mast cells, basophils, and eosinophils", J. Allergy Glitz. Immunol. 111, S486—S494.
  • Boyce, J.A. (2003) "Mast cells: beyond IgE", J. Allergy Clin. Immunol. 111, 24–32.
  • Muzio, M., Bosisio, D., Polentarutti, N., D' amico, G., Stoppacciaro, A., Mancinelli, R., et al. (2000) "Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells", J. Immunol. 164, 5998–6004.
  • Supajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C. and Ogawa, H. (2001) "Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4", J. Immunol. 167, 2250–2256.
  • Tetlow, L.C. and Woolley, D.E. (1995) "Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisa-tion studies", Ann. Rheum. Dis. 54, 896–903.
  • Lee, D.M., Friend, D.S., Gurish, ME, Benoist, C., Mathis, D. and Brenner, M.B. (2002) "Mast cells: a cellular link between autoantibodies and inflammatory arthritis", Science 297, 1689–1692.
  • Dvorak, A.M., Monahan, R.A., Osage, J.E. and Dickersin, G.R. (1978) "Mast cell degranulation in Crohn's disease", Lancet 1, 498.
  • Lorentz, A., Schuppan, D., Gebert, A., Manns, my. and Bischoff, S.C. (2002) "Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins", Blood 99, 966–972.
  • Hawkins, R.A., Claman, H.N., Clark, R.A.F. and Steigerwald, J.C. (1985) "Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis", Ann. Int. Med. 102, 182–186.
  • Garbuzenko, E., Nagler, A., Pickholtz, D., Gillery, P., Reich, R., Maquart, F-X. and Levi-Schaffer, F. (2002) "Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis", Clin. Exp. Allergy 32, 237–246.
  • Secor, V.H., Secor, WE., Gutekunst, C-A. and Brown, M.A. (2000) "Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis", J. Exp. Med. 191, 813–821.
  • Cairns, J.A. and Walls, A.F. (1997) "Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts", J. Clin. Investig. 99, 1313–1321.
  • Matsunaga, Y., Kawasaki, H. and Terada, T. (1999) "Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis", Am. J. Gastroenterol. 94, 1923–1932.
  • Arbustini, E., Gavazzi, A., Dal Bello, B., Morbini, P., Campana, C., Diegoli, M., et al. (1997) "Ten-year experience with endomyo-cardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up", G. Ital. CardioL 27, 209–223.
  • Hara, M., Ono, K., Hwang, M-W., Iwasaki, A., Okada, M., Nakatani, K., et al. (2002) "Evidence for a role of mast cells in the evolution to congestive heart failure", J. Exp. Med. 195, 375–381.
  • Rose, N.R., Hill, S.L. and Neumann, D.A. (1994) "Experimental myocarditis", Autoimmune Disease Models: A Guidebook (Academic Press, San Diego, CA), pp 175–189.
  • Lenzo, J.C., Fairweather, D., Cull, V, Shellam, G.R. and Lawson, C.M. (2002) "Characterisation of murine cytomegalovirus myocar-ditis: cellular infiltration of the heart and virus persistence", J. Mol. Cell. CardioL 34, 629–640.
  • Segal, B.M., Klinman, D.M. and Shevach, EM. (1997) "Cutting edge: microbial products induce autoimmune disease by an IL-12-dependent pathway", J. Immunol. 158, 5087–5090.
  • Caspi, R.R. (1998) "IL-12 in autoimmunity", Clin. Immunol. ImmunopathoL 88, 4–13.
  • Okura, Y, Takeda, K., Honda, S., Hanawa, H., Watanabe, H., Kodama, M., et al. (1998) "Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats", Circ. Res. 82, 1035–1042.
  • Afanasyeva, M., Wang, Y, Kaya, Z., Stafford, E.A., Dohmen, KM., Sadighi Akha, A.A. and Rose, N.R. (2001) "Interleuking-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon--y-independent pathway", Circulation 104, 3145–3151.
  • Fairweather, D. and Rose, N.R. (2002) "Type I diabetes: virus infection or autoimmune disease?", Nat. Immunol. 3, 338–340.
  • Cunningham, M.W. (2001) "Cardiac myosin and the Th 1/Th2 paradigm in autoimmune myocarditis", Am. J. PathoL 159, 5–12.
  • Baboonian, C., Davies, M.J., Booth, J.C. and McKenna, W.J. (1997) "Coxsackie B viruses and human heart disease", Curr. Top. MicrobioL Immunol. 223, 31–52.
  • Horwitz, M.S., La Cava, A., Fine, C., Rodriguez, E., Ilic, A. and Sarvetnick, N. (2000) "Pancreatic expression of interferon-'y protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis", Nat. Med. 6, 693–697.
  • Kaya, Z., Dohmen, KM., Wang, Y, Schlichting, J., Afanasyeva, M., Leuschner, F. and Rose, N.R. (2002) "Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis", J. Immunol. 168, 1552–1556.
  • Perin, D., Roberston, S., Gri, G., Showe, L., Aste-Amezaga, M. and Trinchieri, G. (1998) "Cutting edge: differentiation of human NK cells into NK1 and NK2 subsets", J. Immunol. 161, 5821–5824.
  • Loza, M.J. and Perussia, B. (2001) "Final steps of natural killer cell maturation: a model for typel -type 2 differentiation?", Nat. Immunol. 2, 917–924.
  • Lathbury, L.J., Allan, J.E., Shellam, G.R. and Scalzo, A.A. (1996) "Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection", J. Gen. ViroL 77, 2605–2613.
  • Olson, J.K., Croxford, J.L. and Miller, S.D. (2001) "Virus induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease", Viral Immunol. 14, 227–250.
  • Wucherpfennig, K.W. (2001) "Mechanisms for the induction of autoimmunity by infectious agents", J. Clin. Investig. 108, 1097–1104.
  • Rose, N.R. (1998) "The role of infection in the pathogenesis of autoimmune disease", Semin. Immunol. 10, 5–13.
  • Fujinami, R.S. (2001) "Viruses and autoimmune disease- two sides of the same coin?", Trends MicrobioL 9, 277–281.
  • Olson, J.K., Croxford, J.L., Calendoff, MA., Dal Canto, M.C. and Miller, S.D. (2001) "A virus-induced molecular mimicry model of multiple sclerosis", J. Clin. Investig. 108, 311–318.
  • Deshpande, S.P., Lee, S., Zheng, M., Song, B., Knipe, D., Kapp, J.A. and Rouse, B.T. (2001) "Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis", J. Virol. 75, 3077–3088.
  • Panoutsakopoulou, V, Sanchirico, ME., Huster, KM., Jansson, M., Granucci, F., Shim, D.J., et al. (2001) "Analysis of the relationship between viral infection and autoimmune disease", Immunity 15, 137–147.
  • Gauntt, C.J., Trousdale, M.D., LaBadie, DR., Paque, RE. and Nealon, T. (1979) "Properties of Coxsackievirus B3 variants which are amyocarditic or myocarditic for mice", J. Med. ViroL 3, 207–220.
  • Pflanz, S., Timans, J.C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., et al. (2002) "IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naïve CD4+ T cells", Immunity 16, 779–790.
  • Devergne, 0., Birkenbach, M. and Kieff, E. (1997) "Epstein—Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin", Proc. Natl Acad. Sci. USA 94, 12041–12046.
  • Smith, S.C. and Allen, P.M. (1992) "Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis", Circ. Res. 70, 856–863.
  • Launois, P., Himmelrich, H., Tacchini-Cottier, F., Milon, G. and Louis, J.A. (1999) "New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice", Microbes Infect. 1, 59–64.
  • Hondowicz, B. and Scott, P. (1999) "Influence of host and parasite factors on the innate immune response and Th2 stability following infection with Leishmania major", Micmbes Infect. 1, 65–71.
  • Kehoe, K.E., Brown, MA. and Imani, F. (2001) "Double-stranded RNA regulates IL-4 expression", J. Immunol. 167, 2496–2501.
  • Biron, C.A. (1998) "Role of early cytokines, including alpha and beta interferons (1FN-a113), in innate and adaptive immune responses to viral infections", Semin. Immunol. 10, 383–390.
  • Nieuwenhuis, E.E., Neurath, ME, Corazza, N., Iijima, H., Trgovcich, J., Wirtz, S., et al. (2002) "Disruption of T helper 2-immune responses in Epstein—Barr virus-induced gene 3-deficient mice", PNAS 99, 16951–16956.
  • Afanasyeva, M., Wang, Y, Kaya, Z., Park, S., Zilliox, M.J., Schofield, B.H., et al. (2001) "Experimental autoimmune myocarditis in NJ mice is an interleukin-4-dependent disease with a Th2 phenotype", Am. J. Pathol. 159, 193–203.
  • Lafaille, J.J., Van de Keere, F., Hsu, AL., Baron, J.L., Hass, W., Raine, CS., et al. (1997) "Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease", J. Exp. Med. 186, 307–312.
  • Banda, N.K., Kraus, D., Vondracek, A., Huynh, L.H., Bendele, A., Holers, V.M., et al. (2002) "Mechanisms of effects of complement inhibition in murine collagen-induced arthritis", Arthritis Rheum. 46, 3065–3075.
  • Gor, DO., Rose, N.R. and Greenspan, N.S. (2003) "Thl —Th2: a Procrustean paradigm", Nat. Immunol. 4, 503–505.
  • Leal-Berumen, I., Conlon, P. and Marshall, J.S. (1994) "IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopoly-saccharide", J. Immunol. 152, 5468–5476.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.